4//SEC Filing
Harwin Peter Evan 4
Accession 0001104659-25-098362
CIK 0001953926other
Filed
Oct 8, 8:00 PM ET
Accepted
Oct 9, 4:15 PM ET
Size
10.5 KB
Accession
0001104659-25-098362
Insider Transaction Report
Form 4
Transactions
- Purchase
Common Stock
2025-10-07$19.00/sh+316,219$6,008,161→ 2,209,025 total(indirect: By Fairmount Healthcare Fund II L.P.)
Harwin Peter Evan
Director
Transactions
- Purchase
Common Stock
2025-10-07$19.00/sh+316,219$6,008,161→ 2,209,025 total(indirect: By Fairmount Healthcare Fund II L.P.)
Kiselak Tomas
Director
Transactions
- Purchase
Common Stock
2025-10-07$19.00/sh+316,219$6,008,161→ 2,209,025 total(indirect: By Fairmount Healthcare Fund II L.P.)
Fairmount Funds Management LLC
Director
Transactions
- Purchase
Common Stock
2025-10-07$19.00/sh+316,219$6,008,161→ 2,209,025 total(indirect: By Fairmount Healthcare Fund II L.P.)
Footnotes (1)
- [F1]Fairmount Funds Management LLC ("Fairmount") is the investment manager for Fairmount Healthcare Fund II L.P. The managers of Fairmount are Peter Harwin and Tomas Kiselak. Fairmount, Mr. Harwin, and Mr. Kiselak disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.
Documents
Issuer
Zenas BioPharma, Inc.
CIK 0001953926
Entity typeother
Related Parties
1- filerCIK 0001663607
Filing Metadata
- Form type
- 4
- Filed
- Oct 8, 8:00 PM ET
- Accepted
- Oct 9, 4:15 PM ET
- Size
- 10.5 KB